Effect of preoperative transarterial chemoembolization on perioperative safety of patients with resectable hepatocellular carcinoma: a Meta-analysis

Abstract

Objective To systematically evaluate the effect of transarterial chemoembolization (TACE) on perioperative safety of patients with resectable hepatocellular carcinoma (HCC). Methods Literatures were researched using Chinese Journal Full-text Database, Wanfang database, VIP database, PubMed, Medline from December 1, 1994 to May 30, 2016 with the key words including 肝细胞癌,肝切除,术前化疗栓塞,经动脉化疗栓塞, liver cancer, hepatocellular carcinoma, liver resection, hepatectomy, transcatheter arterial chemoembolization, transarterial chemoembolization, preoperative . Manual retrieval was also conducted simultaneously. The randomized controlled trials (RCTs) about TACE on perioperative safety of patients with resectable HCC were received and enrolled. Patients undergoing surgery after TACE were allocated into the case group and patients undergoing first-stage resection were allocated into the control group. Two reviewers independently screened literatures, extracted data and assessed the risk of bias. Count data were described as relative risk (RR) and 95% confidence interval (CI). Measurement data were represented as standardized mean difference (SMD) and 95%CI. The heterogeneity of the studies was analyzed using the I2 test. Results Five RCTs were enrolled in the Meta analysis, and the total sample size was 430 cases including 212 in the case group and 218 in the control group. Results of Meta analysis showed that there was no statistically significant difference in the hemihepatic resection rate between the 2 groups (RR=0.99, 95%CI: 0.81~1.20, P>0.05). The combined resection rate of perihepatic organs in the case group was significantly higher than that in the control group (RR=3.42, 95%CI: 1.91-6.12, P 5 cm in the case group were respectively longer and higher than these in the control group (SMD=0.31, RR=1.65, 95%CI: 0.06-0.57, 1.01-2.69, P<0.05). Conclusion There is no obvious effect of TACE on resectable HCC, and it can evaluated combined resection rate of perihepatic organs, operation time and incidence of postoperative complications of patients with resectable HCC and an average tumor diameter > 5 cm, and also reduce the perioperative safety. Key words: Carcinoma hepatocellular; Ttransarterial chemoembolization; Hepatectomy; Perioperative period; Meta analysis